A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Clinical trial NCT01064037 · TERMINATED
Trial details
- NCT number
- NCT01064037
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-02-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.